Related Experiment Video
Updated: Jul 8, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
MicroRNAs in the miR-106b family regulate p21/CDKN1A and promote cell cycle progression
Irena Ivanovska1, Alexey S Ball, Robert L Diaz
1Rosetta Inpharmatics LLC, 401 Terry Ave. N, Seattle, WA 98109, USA. irena_ivanovska@merck.com
Abstract:
microRNAs in the miR-106b family are overexpressed in multiple tumor types and are correlated with the expression of genes that regulate the cell cycle. Consistent with these observations, miR-106b family gain of function promotes cell cycle progression, whereas loss of function reverses this phenotype. Microarray profiling uncovers multiple targets of the family, including the cyclin-dependent kinase inhibitor p21/CDKN1A. We show that p21 is a direct target of miR-106b and that its silencing plays a key role in miR-106b-induced cell cycle phenotypes. We also show that miR-106b overrides a doxorubicin-induced DNA damage checkpoint. Thus, miR-106b family members contribute to tumor cell proliferation in part by regulating cell cycle progression and by modulating checkpoint functions.
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
Negative Regulator Molecules
Inhibition of Cdk Activity
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

